PRINCETON, N.J., Oct. 13, 2022 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq:CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2022 after the market close on Monday, November 7th, 2022. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
About Certara
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries. Visit us at www.certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Daniel Yunger
Kekst CNC
daniel.yunger@kekstcnc.com
Related news for (CERT)
- Today’s Top Performers: MoBot’s Market Review 08/07/25 10:00 AM
- Certara Reports First Quarter 2025 Financial Results
- Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization
- MoBot’s Stock Market Highlights – 04/11/25 09:00 AM
- MoBot alert highlights: NASDAQ: SHPH, NASDAQ: ONVO, NASDAQ: ABSI, NASDAQ: RXRX, NASDAQ: CERT (04/10/25 07:00 PM)